Geode Capital Management’s Atossa Therapeutics ATOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Sell |
|
|||||
|
2025
Q1 | $1.92M | Buy |
|
|||||
|
2024
Q4 | $2.66M | Sell |
|
|||||
|
2024
Q3 | $4.28M | Buy |
|
|||||
|
2024
Q2 | $3.3M | Buy |
|
|||||
|
2024
Q1 | $2.18M | Buy |
|
|||||
|
2023
Q4 | $981K | Buy |
|
|||||
|
2023
Q3 | $812K | Sell |
|
|||||
|
2023
Q2 | $1.4M | Sell |
|
|||||
|
2023
Q1 | $878K | Sell |
|
|||||
|
2022
Q4 | $644K | Sell |
|
|||||
|
2022
Q3 | $1.02M | Buy |
|
|||||
|
2022
Q2 | $1.33M | Sell |
|
|||||
|
2022
Q1 | $2.57M | Buy |
|
|||||
|
2021
Q4 | $3.21M | Sell |
|
|||||
|
2021
Q3 | $6.88M | Buy |
|
|||||
|
2021
Q2 | $12.4M | Buy |
|
|||||
|
2021
Q1 | $1.03M | Buy |
|
|||||
|
2020
Q4 | $85K | Hold |
|
|||||
|
2020
Q3 | $217K | Hold |
|
|||||
|
2020
Q2 | $341K | Hold |
|
|||||
|
2020
Q1 | $119K | Hold |
|
|||||
|
2019
Q4 | $141K | Hold |
|
|||||
|
2019
Q3 | $176K | Hold |
|
|||||
|
2019
Q2 | $229K | Buy |
|
|||||
|
2019
Q1 | $166K | Buy |
|
|||||
|
2018
Q4 | $16K | Hold |
|
|||||
|
2018
Q3 | $27K | Hold |
|
|||||
|
2018
Q2 | $34K | Buy |
|
|||||
|
2018
Q1 | $74K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $24K | Hold |
|
|||||
|
2016
Q1 | $29 | Hold |
|
|||||
|
2015
Q4 | $27K | Hold |
|
|||||
|
2015
Q3 | $66K | Hold |
|
|||||
|
2015
Q2 | $97K | Hold |
|
|||||
|
2015
Q1 | $154K | Hold |
|
|||||
|
2014
Q4 | $123K | Hold |
|
|||||
|
2014
Q3 | $116K | Buy |
|
|||||
|
2014
Q2 | $117K | Hold |
|
|||||
|
2014
Q1 | $118K | Buy |
|
|||||
|
2013
Q4 | $62K | Hold |
|
|||||
|
2013
Q3 | $150K | Buy |
|